Monitoring linkage to care for people living with HIV/Aids in Alagoas
DOI:
https://doi.org/10.17058/reci.v16i.20573Keywords:
Síndrome de imunodeficiência adquirida, HIV, Terapia antirretroviral de alta atividade, Epidemiologia, Acesso efetivo aos serviços de saúdeAbstract
Background and Objectives: linkage to care is a structured process for people newly diagnosed with HIV and aims to ensure rapid and efficient access to health services. From this perspective, the objective of this study was to describe the monitoring of linkage to care for people living with HIV/Aids in Alagoas. Methods: this is an ecological, descriptive study, cross-sectional, conducted using the integrated HIV/AIDS care monitoring panel in Alagoas from 2014 to 2024. Data collection was conducted between December 2024 and January 2025 and included sociodemographic and clinical variables of people linked to care, as well as the time between linkage to care and initiation of antiretroviral therapy. Results: 12.112 people living with HIV/AIDS in Alagoas were linked to care, with 90,7% receiving care at services in the state capital. Regarding sociodemographic characteristics, 65,6% were male, 44.3% were between 40 and 59 years old, and 67,1% were of mixed race. It was found that 77% of individuals were undergoing treatment, 84,4% had an undetectable viral load, and 48.2% had started therapy between one and six months after linking to the service. Conclusion: The findings reflect advances in linkage, monitoring effectiveness, and clinical follow-up of people living with HIV/AIDS, but reinforce the importance of decentralizing care in the state, expanding access, and strengthening equity in health services.
Downloads
References
1. Meissner ME, Talledge N, Mansky LM. Molecular Biology and diversification of human retroviruses. Front Virol 2022; 2:872599. http://dx.doi.org/10.3389/fviro.2022.872599.
2. Angelo AT, Alemayehu DS. Adherence and its associated factors among adult HIV-infected patients on antiretroviral therapy in south western Ethiopia, 2020. Patient Prefer Adherenc 2021; 12(15): 299-308. http://dx.doi.org/10.2147/PPA.S298594.
3. Estatísticas globais sobre HIV [Internet]. UNAIDS: Programa Conjunto das Nações Unidas sobre HIV/AIDS (UNAIDS); 2025. Disponível em: https://unaids.org.br/estatisticas/.
4. BRASIL. Ministério da Saúde. Boletim Epidemiológico HIV e Aids 2024. Brasília: Ministério da Saúde; 2024. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2024/boletim_hiv_aids_2024e.pdf/view.
5. BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para manejo da infecção pelo HIV em adultos. Brasília: Ministério da Saúde; 2018. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/pcdts/2013/hiv-aids/pcdt_manejo_adulto_12_2018_web.pdf/view.
6. BRASIL. Ministério da Saúde. Manual do cuidado contínuo de pessoas vivendo com HIV/Aids. Brasília: Ministério da Saúde; 2023. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/manual_cuidado_continuos_pessoas_hiv.pdf.
7. Perdigão REA, Bonolo PF, Silveira MR, et al. Oportunidade de vinculação de pessoas vivendo com HIV em um serviço especializado de saúde, Belo Horizonte (MG). Rev Bras Epidemiol 2020; 23(e200020): 1-15. https://doi.org/10.1590/1980-549720200020.
8. Painel integrado de monitoramento do cuidado do HIV/Aids [Internet]. Brasil: Ministério da Saúde; 2025. Disponível em: https://www.gov.br/saude/pt-br/composicao/svsa/cnie/monitoramento-do-cuidado-do-hiv.
9. Cataldo R, Arancibia M, Stojanova J, Papuzinski C. General concepts in biostatistics and clinical epidemiology: observational studies with cross-sectional and ecological designs. Medwave 2019; 19(8):e7698. http://dx.doi.org/10.5867/medwave.2019.08.7698.
10. Prabhu S, Poongulali S, Kumarasamy, N. Impact of COVID-19 on people living with HIV: a review. J Virus Erad 2020; 6(4): 1-27. http://dx.doi.org/10.1016/j.jve.2020.100019.
11. Dias BRL, Rodrigues TB, Gomes D, et al. The temporal and spatial epidemiology employed in the elimination of the HIV epidemic in the largest capital of the Brazilian rainforest. Trop Med Infect Dis 2022; 7(9): 1-27. http://dx.doi.org/10.3390/tropicalmed7090225.
12. De Sá Pinheiro A, Lima SS, Ferreira GRON, et al. HIV epidemic in a province of the Brazilian Amazon region: temporal trend analysis. J Public Health Res 2021; 11(2). http://dx.doi.org/10.4081/jphr.2021.2513.
13. Martins ERC, Medeiros AS, Oliveira KL, et al. Vulnerabilidade de homens jovens e suas necessidades de saúde. Esc Anna Nery 2020; 24(1): 1-7. https://doi.org/10.1590/2177-9465-EAN-2019-0203.
14. Lima RAF, Miranda-Filho DB, Montarroyos UR, et al. Adherence to antiretroviral therapy and factors associated with non-adherence: a cohort study at two referral services in Brazil. AIDS Care 2023; 35(7): 961-9. https://doi.org/10.1080/09540121.2022.2029814.
15. Cabral JR, Cabral LR, Moraes DCA, et al. Fatores associados à autoeficácia e à adesão da terapia antirretroviral em pessoas com HIV: teoria social cognitiva. Cienc Cuid Saúde. 2021; 20: 1-9. http://dx.doi.org/10.4025/cienccuidsaude.v20i0.58781.
16. Santos AP, Cordeiro JFC, Fracarolli IFL, et al. Instrumentos para avaliar a adesão medicamentosa em pessoas vivendo com HIV: uma revisão de escopo. Rev Saude Pública 2022; 56(112): 1-12. https://doi.org/10.11606/s1518-8787.2022056004475.
17. Mate KKV, Engler K, Lessard D, et al. Barriers to adherence to antiretroviral therapy: identifying priority areas for people with HIV and healthcare professionals. Int J STD AIDS 2023; 34(10): 677-86. https://doi.org/10.1177/09564624231169329.
18. Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 2016; 375(9): 830-9. https://doi.org/10.1056/NEJMoa1600693.
19. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 15(10189): 2428-38. doi: https://doi.org/10.1016/S0140-6736(19)30418-0.
20. Duarte FM, Brasil SA, Lima M, et al. Risk and pleasure in the era of pharmacologically safe sex. Rev Saude Pública. 2024; 58(1): 1-12. https://doi.org/10.11606/s1518-8787.2024058005962.
21. Silva LAVD, Duarte FM, Lima M. “Eu acho que a química entrou em reprovação”: relações afetivo-sexuais de homens jovens vivendo com HIV/Aids e com carga viral indetectável. Sex Salu y Soc (Rio J) 2020; 34: 25-45. https://doi.org/10.1590/1984-6487.sess.2020.34.03.a.
22. Wells N, Philpot S, Murphy D, et al. 'It's like I have this weird superpower': experiences of detectable and undetectable viral load among a cohort of recently diagnosed people living with HIV. Sex Health 2023; 20(3): 195-201. https://doi.org/10.1071/SH23044.
23. BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para manejo da infecção pelo HIV em adultos – Módulo I – Tratamento. Brasília: Ministério da Saúde; 2024. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/pcdts/pcdt_hiv_modulo_1_2024.pdf.
24. BRASIL. Ministério da Saúde. Nota técnica nº 208/2024-CGHA/DATHI/SVSA/MS. Brasília: Ministério da Saúde; 2024. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/notas-tecnicas/2024/sei_0043002749_nota_tecnica_208.pdf/view.
25. Lima MCL, Pinho CM, Dourado CARO, et al. Diagnostic aspects and in-service training in the decentralization of care to people living with HIV. Rev Esc Enferm USP 2021;55(e20210065):1-8. https://doi.org/10.1590/1980-220X-REEUSP-2021-0065.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julya Thereza dos Santos Paixão, Géssyca Cavalcante de Melo, Alice Nunes de Barros, Maria Andreza Marques da Silva, Cleisla Daniel Siqueira, Lays Nogueira Miranda, Lygia Alves Vieira Antas, Rosa Caroline Mata Verçosa de Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
